why choose us

First received: August 22, 2022

Clinical Trial: A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetes Mellitus, Type 2

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Once-weekly Semaglutide S.C. 2.0 mg as Add-on to Dose-reduced Insulin Glargine vs Titrated Insulin Glargine in Participants With Type 2 Diabetes and Overweight

Brief Summary: This study compares semaglutide, together with a lower dose of insulin glargine, to a higher dose of insulin glargine in participants with type 2 diabetes.The study looks at how well the study medicines control blood glucose levels.Participants will either get semaglutide together with a lower dose of insulin glargine or a higher dose of insulin glargine.The study will last for about 47 weeks (approximately 11 months).Participants will have 9 clinic visits, 15 phone/video calls and 1 home visit.Participants…

Read more